Genitourinary Cancers | Specialty

The OncLive Genitourinary Cancer condition center page is a comprehensive resource for clinical news and expert insights across genitourinary (GU) malignancies, including renal cell carcinoma, urothelial carcinoma, and prostate cancer. This section features news articles, interviews in written and video format, and podcasts that focus on the evolving treatment paradigm of GU cancers and emerging research.

Revenue Opportunities and GPOs for Urology Groups

December 12th 2012

Reimbursement Issues in Prostate Cancer, Part II

December 12th 2012

Reimbursement Issues in Prostate Cancer, Part I

December 12th 2012

Dr. Shore on the Management of Patients with CRPC

December 12th 2012

Dr. Shore Discusses Therapy Combination in CRPC

December 12th 2012

Management of Patients with Advanced Prostate Cancer

December 12th 2012

Dr. Shore Reviews Emerging Therapies in Prostate Cancer

December 12th 2012

Emerging Therapies in Prostate Cancer

December 12th 2012

Treatments for Post-Docetaxel Prostate Cancer, Part II

December 12th 2012

Treatments for Post-Docetaxel Prostate Cancer, Part I

December 12th 2012

NCCN Guidelines for Advanced Prostate Cancer

December 12th 2012

Immunotherapy in Advanced Prostate Cancer, Part II

December 12th 2012

Immunotherapy in Advanced Prostate Cancer, Part I

December 12th 2012

Managing ADT-Associated Skeletal-Related Events

December 12th 2012

Prostate Cancer Management: Introduction and Overview

December 12th 2012

Dr. Mayer on Tivozanib in Kidney and Breast Cancer

November 30th 2012

Erica L. Mayer, MD, MPH, assistant professor of medicine at Harvard Medical School and Dana-Farber Cancer Institute, describes studies involving tivozanib, a potent VEGF receptor tyrosine kinase inhibitor.

Temsirolimus/Bevacizumab Not Superior to Standard Treatment With Interferon/Bevacizumab in mRCC

November 29th 2012

The combination of temsirolimus plus bevacizumab was not superior to interferon plus bevacizumab as first-line therapy for patients with clear cell metastatic renal cell carcinoma.

November 2012: Clinical Trials in Progress for Urologic Cancers

November 14th 2012

Urologists in Cancer Care presents summaries of ongoing research relating to a variety of urologic cancers.

Recently Approved Therapies Bring New Understanding in Management of Prostate Cancer

November 2nd 2012

After many years of treating patients with advanced prostate cancer the same way, a host of new drug approvals has not only changed the way urologists manage prostate cancer but their understanding of the disease as well.

Meeting Addresses Challenges Facing Urology Groups in Cancer Care

November 1st 2012

The 2012 LUGPA Annual Meeting is expected to gather more than 100 urology groups to discuss administrative, technological, regulatory, and medical challenges facing practices.